316
Views
27
CrossRef citations to date
0
Altmetric
Review

Global prevalence and economic and humanistic burden of astigmatism in cataract patients: a systematic literature review

, , &
Pages 439-452 | Published online: 06 Mar 2018

Abstract

Purpose

To systematically review the published evidence on the prevalence and economic and humanistic burden of astigmatism in cataract patients.

Materials and methods

For this systematic literature review, the Medline, PubMed, Embase, and Cochrane databases were searched from 1996 to September 2015 for available scientific literature that met the inclusion criteria. Studies published in the English language reporting prevalence and humanistic and economic burden in patients diagnosed with cataract and astigmatism were included.

Results

Of 3,649 papers reviewed, 31 studies from 32 publications met the inclusion criteria of this review. Preexisting astigmatism ≥1 D was present in up to 47% of cataract eyes. The cost burden of residual uncorrected astigmatism after cataract surgery was driven by the cost of spectacles, which was estimated to range from $2,151 to $3,440 in the US and $1,786 to $4,629 in Europe over a lifetime. In cataract patients, both preexisting and postoperative residual astigmatism were associated with poor vision-related patient satisfaction and quality of life, as well as higher spectacle burden. Astigmatism correction during cataract surgery appears to improve visual outcomes and results in overall lifetime cost savings compared to astigmatism correction with postoperative vision correction.

Conclusion

There is a high prevalence of preexisting astigmatism in cataract patients. Although published data are limited, both preoperative astigmatism and postoperative residual astigmatism affect visual function and vision-related quality of life, resulting in increased humanistic burden. Suboptimal correction of astigmatism during cataract surgery drives the continuous need for vision correction with spectacles in the postoperative period. Patients must bear the out-of-pocket expenses, since payers often do not reimburse the cost of spectacles. Greater access to astigmatism correction during cataract surgery could improve visual outcomes and quality of life in patients. More research is required to gain a better understanding of the disease burden of astigmatism in cataract patients.

Introduction

Cataract is an opacification of the lens that leads to decreased visual acuity (VA) and functional disability.Citation1 Cataract is a common and significant cause of visual impairment and the leading cause of preventable blindness worldwide.Citation2 Astigmatism, resulting typically from anterior corneal asymmetry, leads to decreased image quality.Citation3 Astigmatism is measured in both magnitude and direction. Astigmatism of 1–1.5 D or more negatively impacts reading performance and nighttime-driving ability.Citation4,Citation5 Astigmatism in patients with cataract further reduces VA and adversely impacts functional and contrast VA. Uncorrected astigmatism can lead to decreased vision and affect patients’ vision-related quality of life (QoL) and well-being.Citation6

The prevalence of astigmatism and the associated economic and humanistic burden in patients undergoing cataract surgery have been recognized in the international literature, but data from these studies have not been systematically reviewed. Therefore, this systematic literature review was conducted to address this gap and report the published evidence on prevalence, economic burden, and humanistic burden of astigmatism in cataract patients.

Materials and methods

This review followed a standard, systematic review methodology endorsed by the Cochrane CollaborationCitation7 and the National Institute for Health and Care Excellence, the health-technology assessment body of the UK.Citation8 Findings from this review were reported in accordance with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines ().Citation9

Figure 1 PRISMA (preferred reporting items for systematic reviews and meta-analyses) flow diagram.

Figure 1 PRISMA (preferred reporting items for systematic reviews and meta-analyses) flow diagram.

A comprehensive literature search was conducted using predefined search strings () in electronic databases (Medline, Medline In-Process, Embase, and the Cochrane Library). The key search terms focused on identifying studies on prevalence, direct and indirect treatment costs, and patient QoL in cataract patients with astigmatism. All studies reporting prevalence, economic burden, and humanistic burden in cataract patients with preexisting astigmatism (PEA) published in English from 1996 to September 2015 were included. Animal and in vitro studies, non-English-language studies, studies published prior to 1996, and studies that did not meet research objectives were excluded. In addition, abstracts and posters from the following conferences (held from 2010 until September 2015) were searched: American Association of Ophthalmology Congress, World Ophthalmology Congress, Royal College of Ophthalmologists UK Congress, and the European Association for Vision and Eye Research Congress. Reference lists of relevant studies, systematic reviews, or literature reviews were also screened to identify any publication not captured through the systematic search.

Table 1 Search strategy

Following the search process, we screened abstracts of all publications, and excluded publications for further review if they did not fulfill the eligibility criteria. Full-text copies of all publications that fulfilled the eligibility criteria or those lacking sufficient information in the abstract for exclusion were obtained and reviewed, and the eligibility criteria were reapplied. Finally, data were extracted from eligible publications for full review. For the economic burden section, costs reported across studies were inflated to 2017 US$ using consumer price indices published by the Organisation for Economic Co-operation and DevelopmentCitation10 and currency-exchange rates.Citation11,Citation12

Results

The literature search yielded 3,649 citations, of which 31 from 32 publications were identified for inclusion in this review and data extraction performed (). In total, 18 studies from 19 publicationsCitation13Citation31 (one study reported in two publications) reporting prevalence were identified. Five studiesCitation32Citation36 reporting economic burden and eight studiesCitation37Citation44 reporting humanistic burden were identified.

Prevalence of preexisting astigmatism in cataract

provides a summary of studies reporting the prevalence of PEA in cataract patients. Of 18 studies included in this review, nine were retrospective, five cross-sectional, and four prospective in design. The reported mean age of the astigmatic cataract patients was 60.6–75.5 years. A higher proportion of females compared to males reported having PEA and cataract: 53.7%–68.2% across the studies. PEA was measured in cylinder diopters, with reported means of 0.79–1.09 D.

Table 2 Characteristics of studies reporting prevalence of preexisting astigmatism

Across countries, the overall prevalence of astigmatism in cataractous eyes (of any cylinder magnitude) was as follows: Croatia 99%,Citation17 UK 94%,Citation22 South Korea 91.8%,Citation26 and Spain 86.8%,Citation18 indicating that astigmatism is a very common refractive error alongside cataract. However, not all patients would require correction for their astigmatism. In general, cataract and refractive surgeons would aim to correct PEA if it is above a clinically important threshold; however, there is no universally accepted clinically important cylinder diopter-threshold to identify treatment-eligible cataract patients with PEA.

Many studies reported prevalence as a proportion of cataract eyes ≥1 D of PEA.Citation13,Citation16Citation19,Citation23Citation28,Citation31 Using a ≥1 D threshold, the prevalence of PEA ranged between 23%Citation26 in South Korea and 47%Citation31 in China (). At least two studies reported this prevalence as patients who could benefit from PEA correction during cataract surgery.

Figure 2 Prevalence of cataract eyes with ≥1 D of preexisting astigmatism.

Abbreviations: D, diopters; UK, United Kingdom.
Figure 2 Prevalence of cataract eyes with ≥1 D of preexisting astigmatism.

Lyall et al proposed a widely used disease-severity classification approach in clinical practice, ie, categorizing disease severity into mild, moderate, and severe categories for PEA in cataract patients’ severity classification.Citation24 The following thresholds to classify PEA in cataract patients into three categories were proposed: <1.5 D (mild), ≥1.5–<2.5 D (moderate), and ≥2.5 D (significant). We applied this classification to the data reported in various studies, and generated uniform prevalence figures across geographies. With this approach, the prevalence of mild PEA (<1.5 D) ranged between 74.6%Citation31 (China) and 89.6%Citation13,Citation26 (South Korea), moderate PEA (≥1.5–<2.5 D) 8.1%Citation10,Citation13 (Sweden) and 18.6%Citation31 (China), and significant PEA (≥2.5 D) 2%Citation26 (South Korea) and 6.8%Citation28 (Thailand) (). It is evident from the reported data that across countries, the prevalence of clinically relevant PEA in cataract patients is substantial and that these patients could benefit from astigmatism correction during cataract surgery. None of the prevalence studies included in this review reported the prevalence of postoperative astigmatism, which could have provided some insights into astigmatism-correction patterns during cataract surgery.

Figure 3 Distribution of preexisting astigmatic cataract eyes with mild, moderate, or significant astigmatism.

Note: Based on the categorization reported by Lyall et al.Citation24
Abbreviations: D, diopters; UK, United Kingdom.
Figure 3 Distribution of preexisting astigmatic cataract eyes with mild, moderate, or significant astigmatism.

Astigmatism differs from other common refractive conditions (hyperopia and myopia) in that the refractive error is measured in both magnitude and direction. In addition, it can also be measured based on corneal topographical symmetry: irregular astigmatism, which does not conform to any geometric appearance, and regular astigmatism, which is symmetrical across the meridian. Regular astigmatism is defined as with the rule (WTR) when the axis of the correcting minus cylinder was within 180°±30° (the steep meridian of the cornea being within 90°±30° in this case), against the rule (ATR) when the correcting minus-cylinder axis was within 90°±30°, and oblique astigmatism (OA) if it was neither WTR nor ATR.Citation16 The prevalence of astigmatic cataract eyes by the type of astigmatism orientation (WTR, ATR, and OA) was reported in five studies and is presented in .

Figure 4 Distribution of preexisting astigmatic cataract eyes by type of orientation.

Abbreviations: ATR, against the rule; OA, oblique astigmatism; WTR, with the rule.
Figure 4 Distribution of preexisting astigmatic cataract eyes by type of orientation.

The proportion of astigmatic cataract eyes with ATR stigmatism was 39% in Italy,Citation16 45% in Croatia,Citation17 50% in New Zealand,Citation29 and 52.4% in ThailandCitation28 and China.Citation31 The proportion of astigmatic cataract eyes with WTR astigmatism was 15% in New Zealand,Citation29 22% in Croatia,Citation17 22.7% in Thailand,Citation28 30.4% in China,Citation31 and 44% in Italy.Citation16 While the proportion of astigmatic cataract eyes with OA was 15% in New Zealand,Citation29 17% in Italy,Citation16 17.2% in China,Citation31 24.9% in Thailand,Citation28 and 32% in Croatia.Citation17 Based on the reported data, ATR is the most common subtype of regular PEA in cataract patients. These prevalence data on astigmatism subtypes can be helpful for surgeons to plan optimized astigmatism correction during cataract surgery.

Correlations between age and the prevalence and/or severity of PEA in cataract patients were reported in eight studies (four each from Europe and Asia).Citation14,Citation16,Citation18,Citation19,Citation22,Citation24,Citation28,Citation31 A small increment in the magnitude of astigmatism with age was observed in a Spanish cohort.Citation18 Khan and MuhtasebCitation22 reported a gradual increase in the prevalence and severity of PEA with age in the UK population, but Lyall et al,Citation24 also a UK-based study, did not report such a trend. Similarly, De Bernardo et al did not identify an increase of astigmatism with age in an Italian cohort either.Citation16 However, this trend appears to be consistently reported across Asia. In a Thai cohort, a significant correlation between astigmatism severity and age was observed (P<0.001).Citation28 Similar positive results were observed in all the three studies from China, which reported a significant increase in PEA severity and age.Citation14,Citation19,Citation31 A trend was also observed between advancing age and increasing prevalence of ATR astigmatism in all the studies that reported data on both parameters.Citation16,Citation18,Citation19,Citation21,Citation24 Some studies also reported correlations between orientation of regular astigmatism and age. An increase in the frequency of ATR astigmatism was observed with advancing age in cataract patients.Citation16,Citation18,Citation19,Citation21,Citation24 Several studies also reported associations of age and the degree of astigmatism, with characteristic changes in the astigmatic axis from WTR to ATR with advancing age.Citation45Citation48 Based on the review of evidence, the correlation between advancing age and PEA severity remains inconclusive, as findings differed among studies conducted across similar and different geographies. However, cataract being a primarily an age-related condition, the evidence indicates that surgeons planning cataract surgery in older patients should consider PEA levels and plan for the optimum treatment strategy to improve postoperative visual outcomes.

Economic burden

The economic burden of cataract has been widely recognizedCitation49,Citation50 and acknowledged by the ophthalmologic community;Citation51Citation53 however, the economic burden of preexisting and postoperative astigmatism is not widely known. In our search, we identified five studies that reported direct and indirect cost burdens of astigmatism in cataract patients.Citation32Citation36 details the characteristics of the included studies. None of the studies reported preoperative economic burden of astigmatism in cataract patients. The studies published were health-economics analyses that reported the estimated cost of astigmatism correction during cataract surgery, evaluated the cost-effectiveness or cost consequence of astigmatism correcting treatment options, and estimated the cost burden of correcting postoperative residual or uncorrected astigmatism with spectacles.

Table 3 Characteristics of studies reporting economic burden

Laurendeau et al conducted a cost–consequence analysis in four European countries (France, Germany, Italy, and Spain) from a societal perspective, comparing monofocal intraocular lenses (IOLs) to toric IOLs with a focus on their ability to reduce spectacle dependence.Citation32 The rate of spectacle replacement was estimated to be 2–3 years for many patients (33%–48%). A simulated cohort of astigmatic, bilateral IOL recipients undergoing cataract surgery was followed up with a time horizon of 30 years in a Markov model. In this analysis, the estimated cost of cataract surgery per patient, including cost of IOLs (both toric and standard monofocal IOLs considered at parity price), ranged from $1,510 in Spain to $1,740 in Germany. Patients implanted with toric IOLs in France, Spain, Germany, and Italy were estimated to spend between $1,786 and $3,605 on spectacles, while in patients implanted with monofocal IOLs, the costs were estimated to be between $2,313 and $4,629. In all four countries, the lifetime cost-savings associated with toric IOLs ranged from $443 to $978. Savings in the toric IOL group observed were due to less expensive vision correction with spectacles compared to the standard monofocal IOL group.Citation32

Pineda et al conducted a cost-effectiveness analysis comparing toric IOLs with monofocal IOLs (with or without intraoperative refractive correction [IRC] using limbal relaxing incision/peripheral corneal relaxing incision [PCRI]).Citation33 They built a decision-analysis model reflecting the treatment pathway for cataract patients with astigmatism from the US health-care perspective over a span of 18 years. Patients with toric IOLs were estimated to achieve an incremental gain of 13% with regard to spectacle independence versus those with monofocal IOLs without IRC and 4% compared to those with IRC. The toric IOL group was estimated to achieve an incremental gain of 9% in uncorrected VA (UCVA) ≥20/25 versus the monofocal IOL group without IRC and 5% compared to the group with IRC. Incremental quality-adjusted life-year (QALY) gains in patients with toric IOLs versus monofocal IOLs without and with IRC were reported to be 0.1 and 0.06 QALYs, respectively. Postsurgery total lifetime costs associated with toric IOLs were comparable with monofocal IOLs, but costs associated with IRC along with monofocal IOLs were higher than those with toric IOLs or monofocal IOLs alone. In addition, the lifetime cost of spectacle use after cataract surgery was estimated to be higher with monofocal IOLs compared to toric IOLs. Patients with toric IOLs saved $34 over their lifetime compared with those using monofocal IOLs without IRC. The cost savings were sensitive to UCVA achieved ($425 more if UCVA ≥20/25), cost of the toric IOLs, and the likelihood of achieving spectacle independence. Compared to the costs in patients with IRC and monofocal IOLs, patients with toric IOLs saved $230 over their lifetime. The savings reflected higher spectacle independence in the toric IOL group. The lifetime cost saving per patient could be considered negligible, but it is important to note that the toric IOL group also achieved a higher QALY gain for the duration of this model, indicating that toric IOLs were a dominant treatment strategy for cataract patients with PEA.Citation33

Similarly, Ochoa et al conducted a cost-effectiveness study in Colombia to evaluate the cost-effectiveness of toric IOLs versus the use of conventional monofocal IOLs in patients with cataract and PEA >0.75 D from the perspective of third-party payer.Citation34 A decision-tree model simulated the cataract-surgery intervention over a time horizon of 5 years. The cumulative cost of treatment of patients with cataract and PEA >0.75 D with toric IOLs was estimated to be $1,172 compared to $786 with traditional monofocal IOLs up to 5 years after cataract surgery. The incremental cost-effectiveness ratio with toric IOLs was $573 per year of normal vision without additional support compared to traditional monofocal IOLs. A linear relationship between preoperative PEA diopters and ICER was observed, indicating that PEA correction in cataract patients with toric IOL was more cost-effective in patients at the higher end of the severity spectrum.Citation34

As a refractive error, astigmatism can affect patients’ vision and lead to difficulty in performing job-related activities. However, it is important to note that cataract patients are usually older and mostly outside the workforce population, and thus direct productivity loss could be considered of little relevance to society. On the other hand, their caregivers could be part of the working-age population and the condition could be associated with indirect productivity loss. To estimate the direct and indirect costs and associated productivity loss for astigmatic cataract patients, Kim et al conducted a cross-sectional survey in South Korea in cataract patients with and without astigmatism (n=150).Citation35 They reported that time spent on health-care appointments related to astigmatism correction with spectacles was 30–60 minutes for 41% of patients, while 15% of patients spent over 90 minutes. A relative accompanied two-thirds of patients for optometrist appointments. They also reported that patients with post-cataract surgery astigmatism paid approximately twice as much for their spectacles compared to patients without postoperative astigmatism ($452 and $223, respectively). The additional postsurgical lifetime cost of spectacles in cataract patients to correct astigmatism was $2,164 per patient, which was greater than the out-of-pocket costs associated with toric IOLs.Citation35

Health-care resource utilization is an important contributor to the direct health-care costs and could affect hospital budgets. Resource utilization in astigmatic cataract patients was studied and reported by Colin et al.Citation36 Findings suggested that astigmatic cataract patients had longer hospital stay, more comorbidities, and a significant increase in procedures compared to cataract patients without astigmatism. Further, the cost of procedures was higher for astigmatic cataract patients.Citation36 However, these data need to be interpreted with caution, since cataract surgery is almost universally an outpatient procedure in the majority of countries. This review did not identify studies that reported health-care resource utilization in astigmatic cataract patients in the postoperative period, which could have provided some insights into the impact of uncorrected astigmatism on health-care resources.

Humanistic burden

Cataract is known to have impact on patients’ QoL.Citation54 The QoL of cataract patients is further aggravated by the presence of astigmatism. Astigmatism-related vision distortion can lead to decreased visual performance, which increases spectacle dependence and can affect vision-related QoL. As with economic burden, the impact of astigmatism on patients’ vision-related QoL has not been widely acknowledged. We identified eight studies that reported the humanistic burden of astigmatism in patients with cataract.Citation37Citation44

provides a summary of the included evidence. Five studies reported data on patient satisfaction with vision,Citation38,Citation40Citation43 and six studies on spectacle dependence in astigmatic cataract patients.Citation37Citation41,Citation43 Only one study reported the effect of astigmatism on the risk and rate of falls in patients with cataract.Citation44 summarizes the instruments used to assess vision-related QoL in studies included in this review. Different measures were used to evaluate patient satisfaction with vision: the Patient Satisfaction Scale (0–10),Citation38,Citation40,Citation43 standardized 42-item National Eye Institute Refractive Error Quality of Life (NEI RQL-42) questionnaire,Citation41,Citation42 Visual Tasks Difficulty Assessment (VISTAS) questionnaire,Citation43 and 14-item Visual Function (VF-14) index.Citation38 The main findings from each study are reported separately in the following paragraphs, since heterogeneous study designs and different outcomes measures used to report spectacle dependence, satisfaction with vision, and QoL did not allow for evidence summary.

Table 4 Characteristics of studies reporting humanistic burden

Table 5 Instruments used to evaluate quality of life in astigmatic patients with cataract

Spectacle independence is becoming an increasingly important outcome in cataract surgery, including in astigmatic cataract patients.Citation41 Lane et al conducted a prospective multicenter double-arm study in patients with cataract and corneal astigmatism to assess spectacle independence and patient satisfaction with vision over 6 months of follow-up in patients with bilateral toric (n=40 patients) and spherical (n=22 patients) IOLs.Citation37 At 1 month postsurgery, spectacle independence (defined as no use of spectacles for distance vision) was relatively higher in patients who received toric IOLs (97% of patients) compared to those who received spherical IOLs (50% of patients). At the end of the 6-month follow-up, 24% of patients with toric IOL implantation required prescription glasses of any type (bifocals, distance, or reading) compared to 64% of patients in the spherical IOL group.Citation37

Mingo-Botín et al conducted a randomized controlled trial (RCT) measuring spectacle dependence (defined as need to wear distance-vision spectacles) and patient satisfaction in cataract patients with PEA who were implanted with either toric IOLs (n=20) or spherical IOLs with PCRI (n=20).Citation38 The VF-14 index was administered to patients prior to surgery and at 3 months after cataract surgery to assess functional impairment related to vision. Presurgery subjective patient satisfaction with vision was poor in both groups and a large increase in VF-14 index scores and reported satisfaction with vision was reported for both groups, with no significant difference between groups. Presurgery, 85% of patients in the toric IOL group and 80% of patients in the PCRI group wore spectacles to correct distance vision. At 3 months postoperatively, 15% of toric IOL patients required distance-vision spectacles compared to 45% of patients treated with spherical IOLs.Citation38

Holland et al conducted a large multicenter RCT comparing toric IOLs (n=256 patients) to spherical IOLs (n=261 patients) in cataract patients with PEA, and reported postoperative spectacle dependence (defined as any-use spectacles for distance vision) as one of the treatment outcomes. At 6 months postsurgery, 39% of patients with toric IOLs reported some degree of spectacle dependence for distance vision compared with 64% of those with spherical IOLs.Citation39

Ahmed et al conducted a single-arm prospective study to evaluate the efficacy of bilateral toric IOL implantation in astigmatic cataract patients (n=117).Citation40 At 6 months postsurgery, 69% of patients reported independence (defined as no use of spectacles) from distance spectacles. Postsurgery, patients provided satisfaction ratings on a scale of 1 (completely unsatisfied) to 10 (completely satisfied), and 94% of patients rated their satisfaction as 7 or higher. Patient satisfaction was statistically significantly higher postoperatively at 6 months compared to preoperative values (P<0.001).Citation40

Visser et al conducted an RCT in patients with bilateral cataract and bilateral astigmatism (n=86) in the Netherlands.Citation41 One of the outcome measures was spectacle independence in patients who received bilateral toric (n=41) or aspherical (n=45) IOL implantation. At 6 months postoperatively, spectacle independence (defined as no use of spectacles) for distance vision was achieved in 84% of patients implanted with toric IOLs compared to 31% of patients implanted with aspherical IOLs (P<0.01). At 6 months after cataract surgery, no significant differences were identified between the toric IOLs and aspherical IOLs for NEI RQL-42 subscales. Mean scores on the NEI RQL-42 satisfaction with corrections subscale was similar for patients implanted with toric or aspherical IOLs (87 and 83, respectively).Citation41

Mencucci et al conducted a prospective, observational study in patients with bilateral cataract and PEA (n=120) who underwent unilateral cataract surgery.Citation42 Patients were implanted with either spherical or toric IOLs. Postoperatively, patients with toric IOLs achieved significantly better refractive and visual outcomes compared to spherical IOLs. At 3 months after cataract surgery, QoL results were significantly better for the toric IOL group compared to the spherical IOL group, measured using the NEI RQL-42 questionnaire. Further, QoL was significantly better for the toric IOL group compared to the spherical IOL group, measured on NEI RQL subscales related to astigmatism correction, such as clarity of vision (P<0.001), far vision (P=0.021), glare (P=0.038), and satisfaction with correction (P=0.001).Citation42

In a prospective single-arm study with a 6-month follow-up, Knorz et al assessed patient experience with multifocal toric IOLs in Europe and South America.Citation43 The VISTAS questionnaire was administered preoperatively and at all postoperative visits. Preoperatively, 63% of astigmatic cataract patients were completely dissatisfied with their overall vision, which was reduced to 2.4% after astigmatism correction with multifocal toric IOLs. Preoperatively, only 14% patients were spectacle-free, which had increased to 90% at 6 months after cataract surgery. On a scale of 0 (worst) to 10 (best), mean UCVA rating significantly improved from 3.63±1.98 preoperatively (n=38) to 7.89±1.87 at 6 months postoperatively (n=37) (P<0.001).Citation43

Supuk et al conducted a prospective study in the UK to evaluate changes in dizziness and self-reported falls in cataract patients (n=283) with astigmatism before and after cataract surgery (monofocal IOLs). The self-reported fall rate among patients in the 6 months prior to cataract surgery was 23% and had decreased to 20% at 6 months postsurgery; however, findings were statistically nonsignificant. Sensitivity analysis showed a nonsignificant association between fall risk and magnitude of astigmatism.Citation44

Uncorrected astigmatism following cataract surgery appears to affect visual and refractive outcomes, leads to higher spectacle dependence, and is associated with low self-reported satisfaction with vision. This can in turn affect patients’ vision-related QoL. A significant improvement in patient satisfaction was observed postsurgically after correction of astigmatism with toric IOLs. Postoperative spectacle dependence (defined as any use of spectacles) was lower with toric IOLs compared to monofocal IOLs. This review identified only one study that did not report any association between risk of falls and astigmatism.

Discussion

To our knowledge, this is the first systematic review to study the prevalence, humanistic burden, and economic burden of astigmatism in patients with cataract undergoing surgery. This systematic review aimed to synthesize the evidence on the prevalence and economic and humanistic burden of astigmatism in cataract patients.

Based on the available data, there is high prevalence of PEA in cataract patients. The economic burden of astigmatism in cataract patients is mostly driven by postoperative costs of vision correction with spectacles. In addition, indirect costs, such as optometrist, travel, and caregivers’ time, add further to the economic burden on patients and their families. The evidence suggests that astigmatism correction at the time of cataract surgery resulted in better postoperative visual outcomes that can lead to higher satisfaction with vision, reduced need for vision correction with spectacles, and subsequent greater improvement in patients’ vision-related QoL compared to patients in whom astigmatism correction is not attempted during cataract surgery. In addition, astigmatism correction during cataract surgery is a cost-effective or cost-saving approach compared to postoperative vision correction with spectacles.

Despite these benefits, patients in predominantly publicly financed health-care systems prevalent in Europe might not get access to astigmatism correction during cataract surgery, since cataract-surgery reimbursement is governed by fixed tariffs that cover only standard monofocal IOLs. Besides, astigmatism correction during cataract surgery may not be the ultimate clinical goal in many health-care systems, since it can be managed by vision correction with spectacles in the postoperative period.

Currently, public payers do not reimburse the cost of spectacles in many countries, and thus astigmatism correction is not covered in their budgets. Therefore, patients who want to have astigmatism correction during cataract surgery will have to be either covered by their private health-care insurance or will have to pay out of pocket. However, in some systems, such as the UK and Spain, there is no provision for patient copay in public hospitals, and thus patients have almost no choice in choosing the most effective treatment for their astigmatism. On the other side, cataract patients with PEA in predominantly private health-care insurance systems, such as the US, could have access to more effective treatments, such as toric IOLs. A recent study has highlighted the importance of understanding the differences in what patients say about the need for correction, what they do, and how they function with or without correction. All these important aspects should be considered in understanding the construct of spectacle independence.Citation55

The evidence identified in this review had some inherent limitations. The data on prevalence of preoperative astigmatism has not been reported in many countries/regions, most significant of which is the US. The limited evidence on risk of falls and astigmatism in cataract patients suggests the need for more studies to investigate the risk. No population-based cost-of-illness study was identified, and the cost burden in preoperative astigmatic cataract patients is unknown. All the identified studies were interventional studies evaluating preoperative and postoperative economic and humanistic burden, meaning that study populations might not have been representative of astigmatic cataract patients. Further, we acknowledge that the reported economic burden in the published studies was an estimate from economic modeling methods, and then further discounting to 2017 prices could have led to an overestimation of cost data in our findings.

Nevertheless, this literature review has multiple strengths associated with the systematic review methodology. This review was conducted in accordance with the widely accepted Cochrane methodology. A comprehensive search strategy was used to identify the evidence from biomedical databases. In addition, conferences and bibliographies of included studies/literature reviews were hand-searched to identify any unpublished evidence. From a methodology perspective, limitations were mainly related to omission of non-English publications. Although we used a very long search period (1996–2016), some publications reporting data on prevalence and burden of astigmatism may have been missed.

Conclusion

There is high prevalence of PEA in cataract patients. Although published data are limited, both preoperative astigmatism and postoperative residual astigmatism affect visual function and vision-related QoL, resulting in increased humanistic burden. Suboptimal correction of astigmatism during cataract surgery drives the continuous need for vision correction with spectacles in the postoperative period. Patients must bear the out-of-pocket expenses, since payers often do not reimburse the cost of spectacles. Greater access to astigmatism correction during cataract surgery can improve visual outcomes and QoL in patients. More research is required to gain a better understanding of the disease burden of astigmatism in cataract patients.

Acknowledgments

Saisudha Samavedam and Syeda Safura Sultana, both employees of Novartis Healthcare Pvt Ltd, India, assisted with the literature search. Aldo A Martinez of Alcon Laboratories Inc, USA helped in the interpretation of findings from this review.

Disclosure

MD is an employee of Novartis. CB and MSK (at the time of research) are employees of Alcon. The authors report no other conflicts of interest in this work.

References

  • American Optometric AssociationOptometric clinical practice guideline: care of the adult patient with cataract2004 Available from: http://www.aoa.org/documents/optometrists/CPG-8.pdfAccessed January 22, 2017
  • World Health OrganizationVisual impairment and blindness2014 Available from: http://www.who.int/mediacentre/factsheets/fs282/enAccessed November 14, 2016
  • ReadSAVincentSJCollinsMJThe visual and functional impacts of astigmatism and its clinical managementOphthalmic Physiol Opt201434326729424635572
  • NarayanasamySVincentSJSampsonGPWoodJMSimulated astigmatism impairs academic-related performance in childrenOphthalmic Physiol Opt201535181825424167
  • WillsJGillettREastwellEEffect of simulated astigmatic refractive error on reading performance in the youngOptom Vis Sci201289327127622227915
  • WolffsohnJSBhogalGShahSEffect of uncorrected astigmatism on visionJ Cataract Refract Surg201137345446021333869
  • HigginsJPGreenSCochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0LondonCochrane Collaboration2011
  • National Institute for Health and Care ExcellenceGuide to the Methods of Technology AppraisalLondonNICE2013
  • MoherDLiberatiATetzlaffJAltmanDGPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementAnn Intern Med20091514264269W26419622511
  • Organisation for Economic Co-operation and DevelopmentInflation (CPI)2017 Available from: https://data.oecd.org/price/inflation-cpi.htmAccessed October 23, 2017
  • Bloomberg [website on the Internet] Available from: https://www.bloomberg.comAccessed November 10, 2017
  • Reuters [website on the Internet] Available from: http://reuters.comAccessed November 10, 2017
  • BehndigAMontanPSteneviUKugelbergMZetterströmCLundströmMAiming for emmetropia after cataract surgery: Swedish National Cataract Register studyJ Cataract Refract Surg20123871181118622727287
  • ChenWZuoCChenCPrevalence of corneal astigmatism before cataract surgery in Chinese patientsJ Cataract Refract Surg201339218819223141077
  • CuiYMengQGuoHBiometry and corneal astigmatism in cataract surgery candidates from southern ChinaJ Cataract Refract Surg201440101661166925149557
  • De BernardoMZeppaLCennamoMIaccarinoSZeppaLRosaNPrevalence of corneal astigmatism before cataract surgery in Caucasian patientsEur J Ophthalmol201424449450024366768
  • ErcegovićABrajkovićJSuraćIKHaluzanMBPrevalence, distribution and types of corneal astigmatism in cataract surgery patients in Sibenik CountyActa Clin Croat201251227527823115955
  • Ferrer-BlascoTMontes-MicoRPeixoto-de-MatosSCGonzalez-MeijomeJMCervinoAPrevalence of corneal astigmatism before cataract surgeryJ Cataract Refract Surg2009351707519101427
  • GuanZYuanFYuanYZNiuWRAnalysis of corneal astigmatism in cataract surgery candidates at a teaching hospital in Shanghai, ChinaJ Cataract Refract Surg201238111970197723079313
  • CuiYMengQGuoHBiometry and corneal astigmatism before phacoemulsification in southern ChinaPoster presented at: American Academy of Ophthalmology Annual MeetingNovember 10–13, 2012Chicago, IL
  • HoffmannPCHützWWAnalysis of biometry and prevalence data for corneal astigmatism in 23,239 eyesJ Cataract Refract Surg20103691479148520692558
  • KhanMIMuhtasebMPrevalence of corneal astigmatism in patients having routine cataract surgery at a teaching hospital in the United KingdomJ Cataract Refract Surg201137101751175521840163
  • LekhanontKWuthisiriWChatchaipunPVongthongsriAPrevalence of corneal astigmatism in cataract surgery candidates in Bangkok, ThailandJ Cataract Refract Surg201137361361521333886
  • LyallDASrinivasanSNgJKerrEChanges in corneal astigmatism among patients with visually significant cataractCan J Ophthalmol201449329730324862779
  • MiyakeTKamiyaKAmanoRShimizuKCorneal astigmatism before cataract surgeryNippon Ganka Gakkai Zasshi2011115544745321706838
  • OhEHKimHLeeHSHwangKYJooCKAnalysis of anterior corneal astigmatism before cataract surgery using power vector analysis in eyes of Korean patientsJ Cataract Refract Surg20154161256126326189381
  • OstriCFalckLBoberg-AnsGKesselLThe need for toric intra-ocular lens implantation in public ophthalmology departmentsActa Ophthalmol2015935e396e39725377632
  • PrakairungthongNCharukamnoetkanokPIsipraditSPrevalence of preoperative corneal astigmatism in patients undergoing cataract surgery at Mettapracharak Hospital, ThailandJ Med Assoc Thai201598987888226591398
  • RileyAFGrupchevaCNMalikTYCraigJPMcGheeCNThe Auckland Cataract Study: demographic, corneal topographic and ocular biometric parametersClin Exp Ophthalmol200129638138611778808
  • WestinOKoskelaTBehndigAEpidemiology and outcomes in refractive lens exchange surgeryActa Ophthalmol2015931414524889146
  • YuanXSongHPengGHuaXTangXPrevalence of corneal astigmatism in patients before cataract surgery in northern ChinaJ Ophthalmol2014201453641224991429
  • LaurendeauCLafumaABerdeauxGModelling lifetime cost consequences of toric compared with standard IOLs in cataract surgery of astigmatic patients in four European countriesJ Med Econ200912323023719728838
  • PinedaRDenevichSLeeWCWaycasterCPashosCLEconomic evaluation of toric intraocular lens: a short- and long-term decision analytic modelArch Ophthalmol2010128783484020625042
  • OchoaFSimbaquebaERomeroMLopezAAnalysis of cost-effectiveness of use of toric intraocular lenses compared with traditional monofocal lenses in patients with cataracts and pre-existing corneal astigmatismValue Health2014173A286
  • KimHLimSChoBAstigmatism and cost of post-cataract surgery spectacle wear in KoreaValue Health2010137A563
  • ColinXLafumaABerdeauxGCataract surgery cost in patients with and without astigmatism: a French national DRG database analysisValue Health2009127A454
  • LaneSSErnestPMillerKMHilemanKSHarrisBWaycasterCRComparison of clinical and patient-reported outcomes with bilateral AcrySof toric or spherical control intraocular lensesJ Refract Surg2009251089990119835331
  • Mingo-BotínDMuñoz-NegreteFJKimHRMorcillo-LaizRRebolledaGOblancaNComparison of toric intraocular lenses and peripheral corneal relaxing incisions to treat astigmatism during cataract surgeryJ Cataract Refract Surg201036101700170820870116
  • HollandELaneSHornJDErnestPArleoRMillerKMThe AcrySof toric intraocular lens in subjects with cataracts and corneal astigmatism: a randomized, subject-masked, parallel-group, 1-year studyOphthalmology2010117112104211120846724
  • AhmedIIRochaGSlomovicARVisual function and patient experience after bilateral implantation of toric intraocular lensesJ Cataract Refract Surg201036460961620362853
  • VisserNBeckersHJBauerNJToric vs aspherical control intraocular lenses in patients with cataract and corneal astigmatism: a randomized clinical trialJAMA Ophthalmol2014132121462146825256624
  • MencucciRGiordanoCFavuzzaEGicquelJJSpadeaLMenchiniUAstigmatism correction with toric intraocular lenses: wavefront aberrometry and quality of lifeBr J Ophthalmol201397557858223467788
  • KnorzMCRincónJLSuarezESubjective outcomes after bilateral implantation of an apodized diffractive +3.0 D multifocal toric IOL in a prospective clinical studyJ Refract Surg2013291176276724203808
  • SupukEAldersonADaveyCJDizziness, but not falls rate, improves after routine cataract surgery: the role of refractive and spectacle changesOphthalmic Physiol Opt201636218319026549158
  • AsanoKNomuraHIwanoMRelationship between astigmatism and aging in middle-aged and elderly JapaneseJpn J Ophthalmol200549212713315838729
  • LeungTWLamAKDengLKeeCSCharacteristics of astigmatism as a function of age in a Hong Kong clinical populationOptom Vis Sci201289798499222705776
  • LiuYCChouPWojciechowskiRPower vector analysis of refractive, corneal, and internal astigmatism in an elderly Chinese population: the Shihpai Eye StudyInvest Ophthalmol Vis Sci201152139651965722110083
  • SanfilippoPGYazarSKearnsLSherwinJCHewittAWMackeyDADistribution of astigmatism as a function of age in an Australian populationActa Ophthalmol2015935e377e38525585855
  • FattoreGTorbicaACost and reimbursement of cataract surgery in Europe: a cross-country comparisonHealth Econ2008171 SupplS71S8218186033
  • BusbeeBGBrownMMBrownGCSharmaSIncremental cost-effectiveness of initial cataract surgeryOphthalmology2002109360661311874769
  • American Academy of Ophthalmology Cataract and Anterior Segment PanelCataract in the adult eye PPP – 20112011 Available from: www.aao.org/pppAccessed March 24, 2017
  • Royal College of OphthalmologistsCommissioning guide: cataract surgery2015 Available from: https://www.rcophth.ac.uk/publications/commissioning-guide-cataract-surgeryAccessed March 24, 2017
  • Royal College of OphthalmologistsCataract surgery guidelines2010 Available from: https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2010-SCI-069-Cataract-Surgery-Guidelines-2010-SEPTEMBER-2010.pdfAccessed November 10, 2017
  • MoFChoiBCLiFCMerrickJUsing Health Utility Index (HUI) for measuring the impact on health-related quality of Life (HRQL) among individuals with chronic diseasesScientificWorldJournal2004474675715349514
  • MorlockRWirthRJTallySRGarufisCHeichelCWPatient-Reported Spectacle Independence Questionnaire (PRSIQ): development and validationAmerican Journal of Ophthalmology201717810111428341605